NCT03067389View on ClinicalTrials.gov

Combined Breast Cancer Risk Study

CompletedOBSERVATIONAL
Enrollment

553

Participants

Timeline

Start Date

February 6, 2016

Primary Completion Date

January 8, 2019

Study Completion Date

January 8, 2019

Conditions
Hereditary Cancer
Interventions
DIAGNOSTIC_TEST

Diagnostic test

Genetic diagnostic test

Trial Locations (4)

14620

Elizabeth Wende Breast Care, Rochester

33437

Bethesda Health, Boynton Beach

72703

The Breast Center of Northwest Arkansas, Fayetteville

02601

Cuda Women's Health Center, Hyannis

All Listed Sponsors
lead

Myriad Genetic Laboratories, Inc.

INDUSTRY

NCT03067389 - Combined Breast Cancer Risk Study | Biotech Hunter | Biotech Hunter